Qualified as a healthcare professional in 1980 and practiced for ten years prior to a commercial career in spanning over over 31 years in the medical technology sector. Roles include Sales Manager, Vice President Corporate Development, Vice President International Sales and Marketing, Vice President Research and Development (product and clinical), Managing Director UK and Corporate Officer of a publicly traded US corporation (NASDAQ). Since founding CHC Ltd in 2005 I have supported numerous businesses nationally and internationally. This includes a number of Senior contracted and interim positions both short and long term.

 

I am an advocate of health technology innovation, especially in relation to start-up, early stage and mid sized SME's in the life science sector. These are often the crucible of innovation and are unrestricted in their approach and outlook.

 

I former Fellow of the Institute of Directors (2005-2018) and hold the IoD Certificate in Company Direction.

​

​

​

​

​

​

Director of SpheriTech Ltd, a innovator, manufacturer and developer of novel synthetic polymers for life science applications. The synthetic polymers are made from readily available fatty acids and amino acids. The basic polymer is biodegradable in the body, is non-toxic, and has inherent antimicrobial properties. 

 

SpheriTech’s proprietary and patent protected process takes a well-established and widely used and approved food preservative, poly-ε-lysine and elevates it to another level by chemically joining two or more molecules by a covalent bond, with multifunctional carboxylic acids to form either micro-particles or macro-porous structures. SpheriSomes can be augmented with additives and developed to meet specific tasks and requirements and in many different forms (emulsions, solutions, sprays, creams, gels, coatings, films, scaffolds etc.).

​

Past Appointments

​

​

​

​

Commercialisation Consultant - Manchester Metropolitan University. Contracted to provide expertise, support, liaison and facilitation to the Faculty of Science and Engineering on matters concerning the commercial development of the Universities outputs

​

General

 

Advisor to a number of public and private healthcare and life science technology providers and regional and national Health and Social Care programmes that focus on product and service innovation. Member of the Economic and Social Research Council (ESRC) Peer Review Collage, Past Governor on the Governing Council of the Lancashire Teaching Hospitals NHS Foundation Trust (and advisor on the LTHFT Innovation Pathway programme developed to foster collaboration with industry).

 

Contracted through European Tender (OEJU) by one of the England's largest NHS Foundation Trusts to provide Commercial Direction to one of two Department of Health, Pilot Healthcare Technology Co-operatives (2007 – 2012).

 

Although retired Chris continues to support a number of commercial client businesses in various roles.